NCT05282381

Brief Summary

Decisional regret is a negative feeling, involving distress or remorse following a decision. This has been studied in several areas such as psychology, economy or marketing. Patients suffering from end-stage renal disease may choose between dialysis and transplantation. This decision-making process is shared with the nephrologist, who explained to the patient the pros and cons of these two possibilities. Although transplantation offers a better life expectancy and quality of life than dialysis, nothing is known about the proportion of patients regretting their choice to be transplanted. The DONOR study aims to determine the proportion of patients regretting their decision, in a prospective cohort of renal transplant recipients. The decisional regret will be assessed by the DRS ("Decisional Regret Scale"), associated with the RetransQoL, a quality of life questionnaire.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

3.4 years

First QC Date

February 17, 2022

Last Update Submit

November 28, 2023

Conditions

Keywords

Decisional regretKidney transplantationQuality of life

Outcome Measures

Primary Outcomes (1)

  • Decisional regret at 12 months post kidney transplantation, defined as a score ≥30 on the Decisional Regret Scale

    The decisional regret scale consists of five items addressing the notion of regret from different perspectives. The patient is asked to respond to each item using a 5-point Likert-type scale. The results of the Decisional Regret Scale are converted into a score from 0 to 100, with values increasing in multiples of 5. A score of 0 means no regret. Three categories of the DRE score were created: no regret (score = 0), low regret (score between 5 and 25), and moderate to high regret (score ≥ 30

    At 12 months post-transplantation

Secondary Outcomes (3)

  • Specific Quality of Life Scale (ReTransQoL)

    At 1, 3, 6 and 12 months post-transplantation

  • Variation of decisional regret over time, following kidney transplantation, using the Decisional Regret Scale

    At 1, 3, 6 and 12 months post-transplantation

  • Identification of biological, psychological and sociological risk factors for decisional regret at 12 months post kidney transplantation, defined as a score ≥30 on the Decisional Regret Scale

    At baseline, and during the 12 months follow-up period.

Study Arms (1)

Cohort of renal transplant recipients

Behavioral: DRS : Decision Regret Scale

Interventions

The DRS is a self-administered questionnaire including 5 items assessing decisional regret in a score graduated between 0 and 100 (0 = no regret).This scale is associated with the ReTransQoL, a specific quality of life questionnaire. Questionnaires are administrated at 1, 3, 6 and 12 months post-transplantation.

Cohort of renal transplant recipients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who received a kidney transplant in the nephrology department of the Lille University Hospital

You may qualify if:

  • Kidney transplantation in the Lille University Hospital
  • Functional kidney graft after 28 days post transplantation

You may not qualify if:

  • Previous other solid organ transplant
  • Combined transplantation (kidney and liver for example)
  • Cognitive disorders
  • Lack of French language skill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Lille

Lille, 59000, France

RECRUITING

Study Officials

  • Mehdi Maanaoui, MD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2022

First Posted

March 16, 2022

Study Start

February 1, 2022

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations